全文获取类型
收费全文 | 196526篇 |
免费 | 18247篇 |
国内免费 | 7507篇 |
专业分类
耳鼻咽喉 | 1194篇 |
儿科学 | 4624篇 |
妇产科学 | 2686篇 |
基础医学 | 37224篇 |
口腔科学 | 3777篇 |
临床医学 | 12341篇 |
内科学 | 33486篇 |
皮肤病学 | 3247篇 |
神经病学 | 16083篇 |
特种医学 | 3716篇 |
外国民族医学 | 57篇 |
外科学 | 14313篇 |
综合类 | 24123篇 |
现状与发展 | 30篇 |
预防医学 | 8864篇 |
眼科学 | 2296篇 |
药学 | 26046篇 |
21篇 | |
中国医学 | 6775篇 |
肿瘤学 | 21377篇 |
出版年
2024年 | 504篇 |
2023年 | 3089篇 |
2022年 | 6325篇 |
2021年 | 7992篇 |
2020年 | 6748篇 |
2019年 | 7741篇 |
2018年 | 7348篇 |
2017年 | 7241篇 |
2016年 | 7084篇 |
2015年 | 8502篇 |
2014年 | 11865篇 |
2013年 | 13246篇 |
2012年 | 12187篇 |
2011年 | 14450篇 |
2010年 | 12291篇 |
2009年 | 11653篇 |
2008年 | 11051篇 |
2007年 | 9846篇 |
2006年 | 8914篇 |
2005年 | 7590篇 |
2004年 | 6646篇 |
2003年 | 5646篇 |
2002年 | 4374篇 |
2001年 | 3733篇 |
2000年 | 3086篇 |
1999年 | 2802篇 |
1998年 | 2402篇 |
1997年 | 2178篇 |
1996年 | 1883篇 |
1995年 | 1584篇 |
1994年 | 1382篇 |
1993年 | 1165篇 |
1992年 | 969篇 |
1991年 | 867篇 |
1990年 | 715篇 |
1989年 | 599篇 |
1988年 | 513篇 |
1987年 | 416篇 |
1986年 | 422篇 |
1985年 | 802篇 |
1984年 | 822篇 |
1983年 | 581篇 |
1982年 | 645篇 |
1981年 | 509篇 |
1980年 | 420篇 |
1979年 | 369篇 |
1978年 | 282篇 |
1977年 | 222篇 |
1976年 | 206篇 |
1975年 | 142篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Manuel Steiner Andishe Attarbaschi Margit K nig Helmut Gadner Oskar A. Haas Georg Mann 《Pediatric hematology and oncology》2004,22(1):11-16
Constitutional trisomy 21 is the most prominent predisposing factor to childhood leukemia, whereas the t(12;21)(p13;q22) with its molecular genetic counterpart, the TEL/AML1 fusion gene, is the most common acquired chromosomal rearrangement in childhood B-cell precursor (BCP) acute lymphoblastic leukemia (ALL). Thus, it was somewhat surprising that according to the currently available literature the incidence of TEL/AML1+ BCP ALL is extremely low in patients with Down syndrome (DS). To further investigate this issue in a population-based fashion, the authors retrospectively assessed the number of DS patients with a TEL/AML1+ ALL in two consecutive Austrian ALL multicenter trials. Accordingly, they were able to analyze 8 of 10 individuals with DS and a BCP ALL, including 2 who suffered from a TEL/AML1+ leukemia. Based on this observation we concluded that individuals with a constitutional trisomy 21 may have the similar likelihood to develop a TEL/AML1+ leukemia as BCP ALL patients without this specific predisposing factor. 相似文献
92.
皮质发育障碍模型的建立及其致痫敏感性的研究 总被引:1,自引:0,他引:1
目的:建立皮质发育障碍模型,探讨皮质发育障碍模型的敏感性。方法:在SD大鼠孕17d腹腔注入1,3-二氯乙烯-亚硝基脲(BCNU)制作皮质发育障碍模型;Nissl染色观察P60d仔鼠病理变化;选取P60d雄性仔鼠,腹腔注射氯化锂-毛果芸香碱,分别比较两组大鼠癫发生的潜伏期、持续状态时间和死亡率。结果:同龄仔鼠脑组织湿重实验组比对照组显著减轻(P<0.01);Nissl染色显示皮质变薄、皮质层次紊乱、海马区域异位细胞异常聚集;有皮质发育障碍的仔鼠注射氯化锂-毛果芸香碱后,癫发生的潜伏期显著缩短(P<0.01),癫持续状态时间延长(P<0.01),死亡率显著升高(P<0.05)。结论:BCNU致皮质发育障碍模型具有癫易感性。 相似文献
93.
目的:探讨Smad1在青少年特发性脊柱侧凸(AIS)患者骨髓间质干细胞(MSCs)中的表达及其在发病机制中的作用。方法:30例12~18岁志愿者分为两组:AIS组20例,同年龄正常对照组10例。分别从髂前上棘处骨穿刺抽取10ml骨髓,肝素抗凝。采用密度梯度离心法分离MSCs,体外培养并传至P2代行表型鉴定,分别采用RT-PCR及免疫蛋白印记法检测两组患者MSCs中Smad1的表达情况。结果:AIS组与对照组Smad1mRNA水平的平均表达率分别为4.48±0.58和1.03±0.22,蛋白水平的平均表达率分别为2.62±0.55和0.84±0.22。不论是核酸水平还是蛋白水平AIS组Smad1的表达均高于对照组(P<0.01)。结论:Smad1在AIS患者MSCs中表达强度异常,可能与AIS发病的分子机制相关。 相似文献
94.
By substituting the saturated vapour phase tension of the pure normal hydrocarbons described by the Clausius-Clapeyron law into the accepted expression of the specific retention volume (Vg,T), a theoretically coherent and relatively simple mathematical evidence of the elution behaviour of the homologous members has been deduced. It gives exponential retention time dependence on carbon number for isothermal, and nearly equidistant (i.e., approximately linear retention-time dependence on carbon number) elution for linear temperature programmed gas chromatographic runs. The final equations are in close correlation with the experimental results. Special emphasis is placed on the fact that a good approximation—not strict physical laws—have been found. 相似文献
95.
细胞间黏附分子-1在实验性自身免疫性脑脊髓炎大鼠中表达的动态变化及作用 总被引:3,自引:2,他引:1
目的探讨细胞间黏附分子-1(ICAM-1)在实验性自身免疫性脑脊髓炎(EAE)大鼠中表达的动态变化及其作用。方法分别取免疫后第4、6、8、10、12、14、16、18、20天EAE大鼠脑和脊髓制成石蜡切片,行HE染色和ICAM-1半定量免疫组化分析。结果免疫后第8天ICAM-1表达即出现明显上调,早于临床症状的发生;随免疫后时间的延长,ICAM-1表达呈逐渐增高后缓慢下降的变化趋势,并且与EAE大鼠病情评分呈显著正相关(r=0.57,P=0.003)。结论ICAM-1的表达上调可能在EAE发病中具重要作用。 相似文献
96.
Antony E. Shrimpton Robert L. Schelper Reinhold P. Linke John Hardy Richard Crook Dennis W. Dickson Takashi Ishizawa Richard L. Davis 《Neuropathology》2007,27(3):228-232
Over 100 mutations in the presenilin‐1 gene (PSEN1) have been shown to result in familial early onset Alzheimer disease (EOAD), but only a relatively few give rise to plaques with an appearance like cotton wool (CWP) and/or spastic paraparesis (SP). A family with EOAD, seizures and CWP was investigated by neuropathological study and DNA sequencing of the PSEN1 gene. Aβ was identified in leptomeningeal vessels and in cerebral plaques. A single point mutation, p.L420R (g.1508T > G) that gives rise to a missense mutation in the eighth transmembrane (TM8) domain of PS1 was identified in two affected members of the family. p.L420R (g.1508T > G) is the mutation responsible for EOAD, seizures and CWP without SP in this family. 相似文献
97.
AIMS: To establish all-cause and cause-specific death rates, and risk factors for mortality in insulin-treated diabetic individuals living in the province of Canterbury, New Zealand. METHODS: Insulin-treated diabetic subjects (n = 995) on the Canterbury Diabetes Registry were followed up over 15 years and vital status determined. Death rates were standardized and hazard regression was used to model the effects of demographic covariates on relative survival time. RESULTS: There were 419 deaths in 11 226.3 person-years of follow-up with a standardized mortality ratio (SMR) of 2.0 (95% confidence interval (CI) 1.8-2.2). Relative mortality was greatest for the group aged 0-29 years (SMR 3.0 (95% CI 2.4-3.7)). After controlling for diabetes duration and gender, a 10-year increment in age of onset was associated with a 33% decrease in relative hazard (95% CI 29-36%), indicating that excess mortality due to diabetes declines with rising age of onset. After controlling for age of onset and gender, each 10-year increment in duration of diabetes is associated with a 26% decrease in relative hazard (95% CI 24-29%), indicating that with longer survival the mortality hazard approaches the general population hazard. Relative mortalities were increased for cardiovascular, renal and respiratory disease, but not malignancy. Relative mortality from acute metabolic complications was increased in the subgroup with age of onset of diabetes < 30 years and requiring insulin within 1 year of diagnosis. CONCLUSIONS: Mortality rates are high for insulin-treated diabetic individuals relative to the general population. 相似文献
98.
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation 总被引:2,自引:0,他引:2
Rolf N. Barth Christina A. Janus Christine A. Lillesand Nancy A. Radke John D. Pirsch Bryan N. Becker Luis A. Fernandez L. Thomas Chin Yolanda T. Becker Jon S. Odorico Anthony M. D''Alessandro Hans W. Sollinger Stuart J. Knechtle 《Transplant international》2006,19(11):885-892
Campath-1H (alemtuzumab) induction was used for renal transplantation in combination with sirolimus as immunosuppression. We previously reported a high (28%) rate of early rejection with this regimen, and now report 3-year outcomes. Twenty-nine patients were recipients of either deceased donor or non-HLA (Human Leukocyte Antigen) identical living donor primary renal allografts. Clinical parameters including infection, malignancy, kidney function, and kidney histology were followed prospectively for 3 years. Three-year cumulative graft and patient survival were 96% and 100%, respectively. Twenty patients were maintained on steroid-free immunosuppressive regimens, and 15 patients were maintained on monotherapy for immunosuppression (12 on sirolimus). No serious infectious complications were observed and two patients developed basal cell skin cancer. The 3-year results of our initial pilot study demonstrate good graft (96%) and patient (100%) outcomes. Campath-1H induction has yielded a high proportion of patients maintained on immunosuppressive monotherapy (57%) without serious infectious- and no malignancy-related complications. The reported regimen yielded novel insights into both Campath-1H and sirolimus therapy in renal transplantation. Because of the higher incidence of early rejection, we recommend a modified strategy of immunosuppression including a brief course of a calcineurin inhibitor. 相似文献
99.
荆州市成人体检血脂及载脂蛋白状况调查与分析 总被引:1,自引:0,他引:1
目的:调查荆州市部分成年人体检的血脂和载脂蛋白的水平,为临床血脂研究与心血管病防治提供参考。方法:以2003年至2005年来我院体检的1656名成年人为研究对象,检测其血清中胆固醇(TC)、甘油三酯(TG)、载脂蛋白A1(ApoA1)、载脂蛋白B(ApoB)的含量。结果:TC、TG值随年龄增加而增高,女性比男性增高更明显。男性ApoA1和ApoB值在各年龄段基本一致,女性则是随年龄增加而上升。但在60岁以后又下降。老年前期、老年人血脂异常率较高且比较接近。结论:脂类代谢与年龄密切相关,中老年人尤其是女性血脂异常明显增加,表明动脉粥祥硬化性心血管病的风险明显增高。 相似文献
100.
二甲双胍对多囊卵巢综合征患者胰岛素样生长因子-1的影响 总被引:2,自引:0,他引:2
目的探讨二甲双胍对多囊卵巢综合征(PCOS)患者血清胰岛素样生长因子-1(IGF-1)及胰岛素样生长因子结合蛋白-1(IGFBP-1)水平的影响及其作用机制,明确二甲双胍治疗的临床效果。方法2002年1—11月对山西医科大学第二医院24例PCOS患者给予二甲双胍500mg,一日3次,8~24周治疗,比较治疗前后血清IGF-1、IGFBP-1、空腹胰岛素及睾酮水平,并对月经恢复、排卵、妊娠情况进行分析。结果二甲双胍可降低血清空腹胰岛素及睾酮水平,能显著升高IGFBP-1水平,治疗前后血清IGF—1水平差异无显著性。单纯二甲双胍治疗后月经恢复率为41.67%(10/24);自然排卵率为25.00%(6/24),自然妊娠率为12.50%(3/24)。二甲双胍加促排卵治疗共18个周期,排卵周期率66.67%(12/18),妊娠周期率为11.11%(2/18)。结论二甲双胍可以降低血清空腹胰岛素及睾酮水平,增高IGFBP-1水平,可以改善卵泡微环境,有助于月经恢复,提高促排卵和妊娠率.是治疗PCOS的重要手段。 相似文献